Xr Securities LLC Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Xr Securities LLC

  • $342 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 02, 2024
BUY
$120.4 - $237.13 $288,960 - $569,112
2,400 New
2,400 $555,000
Q2 2023

Aug 08, 2023
BUY
$203.88 - $312.0 $305,820 - $468,000
1,500 New
1,500 $346,000
Q4 2022

Jan 03, 2023
BUY
$58.39 - $296.54 $945,918 - $4.8 Million
16,200 New
16,200 $3.92 Million

Others Institutions Holding MDGL

# of Institutions
298
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.76B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email